{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:04:07Z","timestamp":1790309047624,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T00:00:00Z","timestamp":1575504000000},"content-version":"vor","delay-in-days":4690,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1093\/annonc\/mdl384","type":"journal-article","created":{"date-parts":[[2006,10,24]],"date-time":"2006-10-24T14:18:56Z","timestamp":1161699536000},"page":"275-281","source":"Crossref","is-referenced-by-count":11,"title":["Phase II study of bleomycin, vindesine, mitomycin C and cisplatin (BEMP) in recurrent or disseminated squamous cell carcinoma of the uterine cervix"],"prefix":"10.1016","volume":"18","author":[{"given":"I.F.","family":"van Luijk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Coens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.L.","family":"van der Burg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kobierska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Namer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lhomme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Zola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Zanetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.B.","family":"Vermorken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1093\/annonc\/mdl384_bb0010","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1056\/NEJM199604183341606","article-title":"Cancer of the uterine cervix","volume":"334","author":"Cannistra","year":"1996","journal-title":"NEJM"},{"issue":"3","key":"10.1093\/annonc\/mdl384_bb0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.1525-1438.1993.03030129.x","article-title":"The role of chemotherapy in squamous cell carcinoma of the uterine cervix: a review","volume":"3","author":"Vermorken","year":"1993","journal-title":"Int J Gynecol Cancer"},{"issue":"2 Suppl 3","key":"10.1093\/annonc\/mdl384_bb0020","first-page":"16","article-title":"Chemotherapy as a palliative treatment in carcinoma of the uterine cervix","volume":"22","author":"Thigpen","year":"1995","journal-title":"Semin Oncol"},{"issue":"10","key":"10.1093\/annonc\/mdl384_bb0025","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/00001813-200111000-00001","article-title":"The role of chemotherapy in invasive cancer of the cervix uteri: current standards and future prospects","volume":"12","author":"Rein","year":"2001","journal-title":"Anticancer Drugs"},{"issue":"1","key":"10.1093\/annonc\/mdl384_bb0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11912-001-0040-5","article-title":"Chemotherapy for advanced or recurrent carcinoma of the cervix","volume":"3","author":"Bloss","year":"2001","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"10.1093\/annonc\/mdl384_bb0035","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1200\/JCO.1997.15.1.165","article-title":"Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study","volume":"15","author":"Omura","year":"1997","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1093\/annonc\/mdl384_bb0040","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1023\/A:1011165115426","article-title":"Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma of the uterine cervix: an EORTC Gynecological Cancer Cooperative Group study","volume":"12","author":"Vermorken","year":"2001","journal-title":"Ann Oncol"},{"issue":"15","key":"10.1093\/annonc\/mdl384_bb0045","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1200\/JCO.2004.04.170","article-title":"Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study","volume":"22","author":"Moore","year":"2004","journal-title":"J Clin Oncol"},{"issue":"21","key":"10.1093\/annonc\/mdl384_bb0050","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1200\/JCO.2005.10.021","article-title":"Randomized phase III trial of cisplatin (P) with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study","volume":"23","author":"Long","year":"2005","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1093\/annonc\/mdl384_bb0055","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1200\/JCO.1998.16.3.1094","article-title":"Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix","volume":"16","author":"Morris","year":"1998","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1093\/annonc\/mdl384_bb0060","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1200\/JCO.1999.17.3.756","article-title":"Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervix","volume":"17","author":"Pignata","year":"1999","journal-title":"J Clin Oncol"},{"issue":"2 Pt 2","key":"10.1093\/annonc\/mdl384_bb0065","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S0090-8258(03)00338-X","article-title":"Gemcitabine in cervical cancer","volume":"90","author":"Mutch","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1093\/annonc\/mdl384_bb0070","first-page":"373","article-title":"Chemotherapy of cervical carcinoma","volume":"9","author":"Muscato","year":"1982","journal-title":"Semin Oncol"},{"issue":"5","key":"10.1093\/annonc\/mdl384_bb0075","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1046\/j.1525-1438.2000.010005358.x","article-title":"Phase II study of vincristine, bleomycin, mitomycin C and cisplatin (VBMP) in disseminated squamous cell carcinoma of the uterine cervix","volume":"10","author":"Vermorken","year":"2000","journal-title":"Int J Gynecol Cancer"},{"key":"10.1093\/annonc\/mdl384_bb0080","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S0959-8049(01)00178-2","article-title":"Phase II study of mitomycin-C and cisplatin in disseminated squamous cell carcinoma of the uterine cervix. A European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group Study","volume":"37","author":"Wagenaar","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdl384_bb0085","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1525-1438.1991.tb00050.x","article-title":"Phase II study of vindesine in disseminated squamous cell carcinoma of the uterine cervix: an EORTC Gynecological Cancer Cooperative Group study","volume":"1","author":"Vermorken","year":"1991","journal-title":"Int J Gynecol Cancer"},{"key":"10.1093\/annonc\/mdl384_bb0090","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdl384_bb0095","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1093\/annonc\/mdl384_bb0100","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"J Roy Stat Soc B"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419376057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419376057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/18\/2\/275\/695055\/mdl384.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T17:15:33Z","timestamp":1736615733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419376057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0923753419376057"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdl384","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}